Overview

Aging adipose tissue develops a stiff, crosslinked ECM driven by hypoxia‑induced HIF1α, increased collagen VI synthesis, and LOX‑mediated crosslinking adipose ECM remodeling. This fibrotic niche limits adipocyte expansion, activates NF‑κB and RhoA pathways, and fuels insulin resistance adipose mechanosignaling. Parallel work shows that the aging brain shifts from plastic NMDA‑receptor LTP to stable LTCC‑dependent LTP, preserving existing memories while resisting new learning hippocampal plasticity shift, LTCC‑LTP evidence. Both tissues share LOX‑dependent collagen remodeling and integrin‑mediated mechanotransduction shared ECM pathways. Yet no study has tested whether adipose‑derived ECM signals directly remodel brain ECM.

Hypothesis

We propose that soluble LOX activity and collagen‑derived peptides released from fibrotic adipose tissue cross the blood‑brain barrier, augment LOX‑mediated crosslinking in the hippocampal ECM, increase tissue stiffness, and bias synaptic plasticity toward LTCC‑LTP. In this view, age‑related cognitive rigidity is not a neuronal loss but a mechanochemical signal from peripheral fat that over‑consolidates neural circuits.

Mechanistic Rationale

1. Adipose LOX secretion – Hypertrophic adipocytes upregulate LOX transcription via HIF1α; LOX is secreted into the circulation adipose LOX expression.
2. Blood‑brain barrier permeability – Age‑related BBB leakiness permits macromolecules >10 kDa to enter the brain parenchyma; LOX (~50 kDa) and collagen fragments can therefore reach the hippocampus BBB permeability in aging.
3. ECM stiffening in brain – LOX catalyzes lysine crosslinking of collagen IV and laminin in the basal lamina, raising elastic modulus measured by MR elastography brain LOX activity.
4. Mechanotransduction to neurons – Increased ECM stiffness engages integrin‑β1‑FAK‑RhoA signaling in astrocytes and neurons, dampening NMDA‑receptor mobility and favoring LTCC clustering at synapses integrin mechanotransduction.
5. Shift in LTP phenotype – Stiff ECM suppresses NMDA‑dependent LTP while promoting LTCC‑dependent LTP, reproducing the plasticity‑to‑stability switch seen in aged hippocampi LTP phenotype switch.
6. Feedback loop – Neuronal activity‑dependent release of TGF‑β1 further stimulates astrocytic LOX, reinforcing ECM rigidity TGF‑β1 loop.

Testable Predictions

• Prediction 1: Serum LOX activity and circulating collagen‑VI peptides will correlate positively with hippocampal stiffness (MR elastography) and negatively with scores on pattern‑separation tasks in middle‑aged mice.
• Prediction 2: Genetic deletion of LOX specifically in adipocytes (Adipoq‑Cre;Lox^fl/fl) will attenuate age‑related increases in brain ECM crosslinking (hydroxyproline assay) and preserve NMDA‑LTP magnitude.
• Prediction 3: Pharmacological LOX inhibition (β‑aminopropionitrile) administered after obesity onset will reverse hippocampal stiffening and restore spatial learning without altering adipocyte size.
• Prediction 4: Ex vivo application of adipose‑conditioned medium to hippocampal slices will increase ECM stiffness and shift LTP from NMDA‑ to LTCC‑dependence, an effect blocked by LOX neutralizing antibody.

Potential Experiments

• Measure plasma LOX activity via fluorometric assay in young, middle‑aged, and obese mice; correlate with hippocampal tensile strength using atomic force microscopy.
• Perform adipocyte‑specific LOX knockout; assess memory via Morris water maze and novel object location; quantify brain collagen crosslinking by HPLC‑derived hydroxyproline.
• Treat obese mice with LOX inhibitor; evaluate BBB integrity (Evans blue extravasation) to ensure central effects are not secondary to vascular leak.
• Apply adipocyte‑conditioned medium to acute hippocampal slices; record field excitatory postsynaptic potentials while pharmacologically isolating NMDA‑ vs LTCC‑LTP components; add LOX antibody to test necessity.

Implications

If peripheral fat can dictate brain ECM mechanics, interventions targeting adipose LOX—such as diet, exercise, or LOX‑blocking antibodies—may serve as geroprotective strategies that preserve cognitive flexibility by preventing maladaptive over‑consolidation. This reframes cognitive aging as a tractable mechanobiological problem rather than an inevitable neurodegenerative decline.